NASDAQ •
Healthcare •
Biotechnology •
Quote as of 11/03/2026 14:38
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization29.76 mln
Float12.82 mln
Earnings Date11/12/2026
1-Year Forecast
7.50
Transformational upside
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
0.01
Debt-free
ROE
-66.22
Deeply negative
ROA
-60.46
Deeply negative
Business Description
Aardvark Therapeutics is a San Diego-based drug development company founded in 2017. It works on creating oral medicines that trigger the body's natural processes to help treat conditions like obesity and diabetes.
